Signaturefd LLC Raises Stock Position in Encompass Health Co. (NYSE:EHC)

Signaturefd LLC increased its stake in Encompass Health Co. (NYSE:EHC) by 21.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 704 shares of the company’s stock after acquiring an additional 125 shares during the period. Signaturefd LLC’s holdings in Encompass Health were worth $65,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Raymond James Financial Inc. acquired a new position in shares of Encompass Health in the 4th quarter valued at $77,944,000. Point72 Asset Management L.P. lifted its stake in Encompass Health by 2,458.5% in the third quarter. Point72 Asset Management L.P. now owns 869,104 shares of the company’s stock valued at $83,990,000 after buying an additional 835,135 shares during the last quarter. Jennison Associates LLC acquired a new stake in shares of Encompass Health in the fourth quarter valued at approximately $52,094,000. abrdn plc purchased a new position in shares of Encompass Health during the fourth quarter worth approximately $17,846,000. Finally, Franklin Resources Inc. raised its position in Encompass Health by 22.0% in the 3rd quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock valued at $67,412,000 after purchasing an additional 126,000 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Encompass Health Stock Up 3.0 %

Shares of NYSE EHC opened at $99.99 on Tuesday. The stock has a market capitalization of $10.07 billion, a price-to-earnings ratio of 22.42, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. Encompass Health Co. has a 52 week low of $76.11 and a 52 week high of $104.55. The firm has a 50-day moving average price of $98.13 and a 200 day moving average price of $97.20. The company has a quick ratio of 1.04, a current ratio of 1.05 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, topping the consensus estimate of $1.05 by $0.12. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. Equities research analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 0.68%. The ex-dividend date is Tuesday, April 1st. Encompass Health’s dividend payout ratio (DPR) is presently 15.25%.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. StockNews.com upgraded shares of Encompass Health from a “hold” rating to a “buy” rating in a research note on Saturday, February 15th. Barclays boosted their price target on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. KeyCorp lifted their target price on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research note on Monday, February 10th. William Blair restated an “outperform” rating on shares of Encompass Health in a research note on Friday, February 7th. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $110.00 price objective on shares of Encompass Health in a research report on Tuesday, February 11th. Ten investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus target price of $107.67.

Insider Buying and Selling

In related news, CAO Andrew L. Price sold 5,042 shares of the company’s stock in a transaction that occurred on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total value of $495,578.18. Following the sale, the chief accounting officer now owns 69,164 shares of the company’s stock, valued at approximately $6,798,129.56. This represents a 6.79 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 2.10% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.